Literature DB >> 18594326

Turning gray: the natural history of lung cancer over time.

Frank C Detterbeck1, Christopher J Gibson.   

Abstract

As newer therapies for lung cancer are being explored it becomes more important to understand the natural history of lung cancer. A systematic review of the data shows that untreated lung cancer is almost uniformly rapidly fatal, even if it is stage I. Analysis of data regarding tumor volume doubling times shows that conventionally detected lung cancers have short mean doubling times, and only a small proportion with very long doubling times. Lung cancers found during the course of a CT screening program have markedly longer mean doubling times and a substantially greater proportion with very long doubling times (>400 days). Models of tumor growth, however, are not understood well enough to use the observed doubling time to predict length of survival without treatment.

Entities:  

Mesh:

Year:  2008        PMID: 18594326     DOI: 10.1097/JTO.0b013e31817c9230

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN: 1556-0864            Impact factor:   15.609


  46 in total

1.  Optimization of dosing for EGFR-mutant non-small cell lung cancer with evolutionary cancer modeling.

Authors:  Juliann Chmielecki; Jasmine Foo; Geoffrey R Oxnard; Katherine Hutchinson; Kadoaki Ohashi; Romel Somwar; Lu Wang; Katherine R Amato; Maria Arcila; Martin L Sos; Nicholas D Socci; Agnes Viale; Elisa de Stanchina; Michelle S Ginsberg; Roman K Thomas; Mark G Kris; Akira Inoue; Marc Ladanyi; Vincent A Miller; Franziska Michor; William Pao
Journal:  Sci Transl Med       Date:  2011-07-06       Impact factor: 17.956

2.  Noninvasive characterization of the histopathologic features of pulmonary nodules of the lung adenocarcinoma spectrum using computer-aided nodule assessment and risk yield (CANARY)--a pilot study.

Authors:  Fabien Maldonado; Jennifer M Boland; Sushravya Raghunath; Marie Christine Aubry; Brian J Bartholmai; Mariza Deandrade; Thomas E Hartman; Ronald A Karwoski; Srinivasan Rajagopalan; Anne-Marie Sykes; Ping Yang; Eunhee S Yi; Richard A Robb; Tobias Peikert
Journal:  J Thorac Oncol       Date:  2013-04       Impact factor: 15.609

Review 3.  Preoperative evaluation for lung cancer resection.

Authors:  Dionysios Spyratos; Paul Zarogoulidis; Konstantinos Porpodis; Nikolaos Angelis; Antonios Papaiwannou; Ioannis Kioumis; Georgia Pitsiou; Athanasia Pataka; Kosmas Tsakiridis; Andreas Mpakas; Stamatis Arikas; Nikolaos Katsikogiannis; Ioanna Kougioumtzi; Theodora Tsiouda; Nikolaos Machairiotis; Stavros Siminelakis; Michael Argyriou; Maria Kotsakou; George Kessis; Alexander Kolettas; Thomas Beleveslis; Konstantinos Zarogoulidis
Journal:  J Thorac Dis       Date:  2014-03       Impact factor: 2.895

4.  Comparing the benefits of screening for breast cancer and lung cancer using a novel natural history model.

Authors:  Ray S Lin; Sylvia K Plevritis
Journal:  Cancer Causes Control       Date:  2011-11-25       Impact factor: 2.506

5.  Long-term follow-up of persistent pulmonary pure ground-glass nodules with deep learning-assisted nodule segmentation.

Authors:  Lin-Lin Qi; Bo-Tong Wu; Wei Tang; Li-Na Zhou; Yao Huang; Shi-Jun Zhao; Li Liu; Meng Li; Li Zhang; Shi-Chao Feng; Dong-Hui Hou; Zhen Zhou; Xiu-Li Li; Yi-Zhou Wang; Ning Wu; Jian-Wei Wang
Journal:  Eur Radiol       Date:  2019-09-04       Impact factor: 5.315

6.  Sensitivity of chest X-ray for detecting lung cancer in people presenting with symptoms: a systematic review.

Authors:  Stephen H Bradley; Sarah Abraham; Matthew Ej Callister; Adam Grice; William T Hamilton; Rocio Rodriguez Lopez; Bethany Shinkins; Richard D Neal
Journal:  Br J Gen Pract       Date:  2019-11-28       Impact factor: 5.386

7.  Natural history of pathologically confirmed pulmonary subsolid nodules with deep learning-assisted nodule segmentation.

Authors:  Lin-Lin Qi; Jian-Wei Wang; Lin Yang; Yao Huang; Shi-Jun Zhao; Wei Tang; Yu-Jing Jin; Ze-Wei Zhang; Zhen Zhou; Yi-Zhou Yu; Yi-Zhou Wang; Ning Wu
Journal:  Eur Radiol       Date:  2020-11-21       Impact factor: 5.315

8.  Natural growth and disease progression of non-small cell lung cancer evaluated with 18F-fluorodeoxyglucose PET/CT.

Authors:  Jingbo Wang; Pawinee Mahasittiwat; Ka Kit Wong; Leslie E Quint; Feng-Ming Spring Kong
Journal:  Lung Cancer       Date:  2012-07-28       Impact factor: 5.705

9.  Patterns of care in hilar node-positive (N1) non-small cell lung cancer: A missed treatment opportunity?

Authors:  Matthew J Bott; Aalok P Patel; Vivek Verma; Traves D Crabtree; Daniel Morgensztern; Clifford G Robinson; Graham A Colditz; Saiama Waqar; Daniel Kreisel; A Sasha Krupnick; G Alexander Patterson; Stephen Broderick; Bryan F Meyers; Varun Puri
Journal:  J Thorac Cardiovasc Surg       Date:  2016-03-12       Impact factor: 5.209

10.  Noninvasive risk stratification of lung adenocarcinoma using quantitative computed tomography.

Authors:  Sushravya Raghunath; Fabien Maldonado; Srinivasan Rajagopalan; Ronald A Karwoski; Zackary S DePew; Brian J Bartholmai; Tobias Peikert; Richard A Robb
Journal:  J Thorac Oncol       Date:  2014-11       Impact factor: 15.609

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.